Skip to main content
. 2018 Aug 7;3(2):177–188. doi: 10.1007/s41669-018-0089-9

Fig. 1.

Fig. 1

Study design scheme. PP1M once-monthly paliperidone palmitate, PP3M once-every-3-months paliperidone palmitate